Leading Therapy development globally (USA, Europe & Australia)Managing patient selection and enrollmentPhysician Training and proctoringCommunication/Marketing and KOL interactions

Managed R&D and production teams.Trained clinical study investigators and provided clinical support.Recruited physicians and Key Opinion Leaders.Managed patient selection and enrollment.Formalized physician feedback, root-cause analysis of events and provided an interface with R&D.Conference preparation, meeting with KOL, session coverage.IP portfolio management and creation.Website and Press Release management.

Currently developing a transcatheter mitral valve replacement technology. Designing the artificial mitral valve and the stent frame. Co-invented with Mr. Georg Börtlein, founder of HighLife, several patented technologies for the Company. Mr. Börtlein is a successful co-founder of start-ups including Corevalve, later acquired by Medtronic in 2009. Designing the delivery catheter and the procedure catheters. Designing the stent's compression system. Performing 3D modelization,… Show more Currently developing a transcatheter mitral valve replacement technology. Designing the artificial mitral valve and the stent frame. Co-invented with Mr. Georg Börtlein, founder of HighLife, several patented technologies for the Company. Mr. Börtlein is a successful co-founder of start-ups including Corevalve, later acquired by Medtronic in 2009. Designing the delivery catheter and the procedure catheters. Designing the stent's compression system. Performing 3D modelization, managing prototypes, supply chain and R&D human resources. Performing and managing pre-clinical operations, acute and chronic.Directly working in collaboration with world-reknowned health professionals.Also created a logo and communication material for the company. HighLife SAS has raised €4.2 million from Sorin Group on November 26, 2012, in a series A round financing. Show less

Developed 3 different technologies for mitral valve repair. Managed prototyping and supply chain. Performed and managed pre-clinical studies, acute and chronic. Produced patentable concepts for different cardiovascular devices (mitral valve replacement, mitral valve repair, percutaneous LAA closure...)

Took part in developing a wound dressing made of biopolymers and metallic nanoparticles. Established an extensive bibliography on the nanoparticles and their method of production. Produced and characterized nanoparticles for the application. Produced prototypes of the wound dressing for cytotoxicity evaluation. Worked in an ISO 9001 and ISO 13485 environment.